U.S. Drug Of Abuse Testing Services Market (2025 - 2030) Size, Share & Trends Analysis Report By Drug (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Drug
                        1.2.2. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Drug outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Drug of Abuse Testing Services Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising prevalence of substance use in the workplace
                            3.2.1.2. Stringent laws mandating alcohol and drug testing in the workplace
                            3.2.1.3. Rapid growth in illicit substance consumption
                        3.2.2. Market restraint analysis
                            3.2.2.1. Changing legal environment and societal norms
                        3.2.3. Market opportunity analysis
                            3.2.3.1. Technological advancements in drug testing for workplace
                        3.2.4. Market risk analysis
                            3.2.4.1. Potential for legal and regulatory changes
                    3.3. U.S. Drug of Abuse Testing Services Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Drug of Abuse Testing Services Market: Drug Estimates & Trend Analysis
                    4.1. Drug Market Share, 2024 & 2030
                    4.2. Segment Dashboard
                    4.3. U.S. U.S. Drug of Abuse Testing Services Market by Drug Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Alcohol
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        4.4.2. Cannabis/Marijuana
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Cocaine
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Opioids
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.5. Amphetamine & Methamphetamine
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.6. LSD
                            4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.7. Others
                            4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
                    5.1. Recent Developments & Impact Analysis, By Key Market Participants
                    5.2. Company/Competition Categorization
                    5.3. Vendor Landscape
                        5.3.1. Key company market share analysis, 2024
                        5.3.2. Quest Diagnostics
                            5.3.2.1. Company overview
                            5.3.2.2. Financial performance
                            5.3.2.3. Product benchmarking
                            5.3.2.4. Strategic initiatives
                        5.3.3. Abbott
                            5.3.3.1. Company overview
                            5.3.3.2. Financial performance
                            5.3.3.3. Product benchmarking
                            5.3.3.4. Strategic initiatives
                        5.3.4. Clinical Reference Laboratory (CRL), Inc.
                            5.3.4.1. Company overview
                            5.3.4.2. Financial performance
                            5.3.4.3. Product benchmarking
                            5.3.4.4. Strategic initiatives
                        5.3.5. Laboratory Corporation of America Holdings
                            5.3.5.1. Company overview
                            5.3.5.2. Financial performance
                            5.3.5.3. Product benchmarking
                            5.3.5.4. Strategic initiatives
                        5.3.6. Cordant Health Solutions
                            5.3.6.1. Company overview
                            5.3.6.2. Financial performance
                            5.3.6.3. Product benchmarking
                            5.3.6.4. Strategic initiatives
                        5.3.7. Legacy Medical Services
                            5.3.7.1. Company overview
                            5.3.7.2. Financial performance
                            5.3.7.3. Product benchmarking
                            5.3.7.4. Strategic initiatives
                        5.3.8. DrugScan
                            5.3.8.1. Company overview
                            5.3.8.2. Financial performance
                            5.3.8.3. Product benchmarking
                            5.3.8.4. Strategic initiatives
                        5.3.9. Omega Laboratories, Inc.
                            5.3.9.1. Company overview
                            5.3.9.2. Financial performance
                            5.3.9.3. Product benchmarking
                            5.3.9.4. Strategic initiatives
                        5.3.10. Psychemedics Corporation
                            5.3.10.1. Company overview
                            5.3.10.2. Financial performance
                            5.3.10.3. Product benchmarking
                            5.3.10.4. Strategic initiatives
                        5.3.11. Millennium Health, LLC
                            5.3.11.1. Company overview
                            5.3.11.2. Financial performance
                            5.3.11.3. Product benchmarking
                            5.3.11.4. Strategic initiatives

List of Tables

Table 1 List of Tables
Table 2 List of Secondary Sources
Table 3 List of Abbreviations
Table 4 U.S. U.S. Drug of Abuse Testing Services Market, by Drug, 2018 - 2030 (USD Million)
Table 5 Regulatory authority for medical cannabis in the U.S
Table 6 Alcohol Consumption in the U.S. by State
Table 7 Marijuana legality by U.S. state, in 2024
Table 8 Percentage of cocaine use in the U.S. by State
Table 9 Methamphetamine Use by Age Group: Prevalence and Population Data in U.S., in 2023
Table 10 Company market share, 2024
Table 11 Key companies undergoing mergers & acquisitions
Table 12 Key companies undergoing collaborations & partnerships
Table 13 Key companies undergoing new product launches
Table 14 Key companies undertaking other activities

List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Drug of abuse testing services, Market Segmentation
Fig. 8 Market Snapshot, 2024
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Represents testing results for each industry in Maine, categorized by the North American Industrial Classification System (NAICS) code., 2023
Fig. 16 Substance use: Among people aged 12 years or older; 2023 (Millions)
Fig. 17 U.S. Drug of Abuse Testing Services Market: Drug Movement Analysis
Fig. 18 U.S. Drug of Abuse Testing Services Market, for Alcohol, 2018 - 2030 (USD Million)
Fig. 19 U.S. Drug of Abuse Testing Services Market, for Cannabis/Marijuana, 2018 - 2030 (USD Million)
Fig. 20 U.S. Drug of Abuse Testing Services Market, for Cocaine, 2018 - 2030 (USD Million)
Fig. 21 U.S. Drug of Abuse Testing Services Market, for Opioids, 2018 - 2030 (USD Million)
Fig. 22 U.S. Drug of Abuse Testing Services Market, for Amphetamine & Methamphetamine, 2018 - 2030 (USD Million)
Fig. 23 U.S. Drug of Abuse Testing Services Market, for LSD, 2018 - 2030 (USD Million)
Fig. 24 U.S. Drug of Abuse Testing Services Market, for Others, 2018 - 2030 (USD Million)